Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
MD1003
.
Show all posts
Showing posts with label
MD1003
.
Show all posts
Tuesday, September 29, 2015
MedDay announces additional positive results from MD1003 Phase III trial in patients with progressive MS
›
MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Ph...
›
Home
View web version
